282 related articles for article (PubMed ID: 31151441)
1. The acquisition of long-lived memory B cell responses to merozoite surface protein-8 in individuals with Plasmodium vivax infection.
Kochayoo P; Kittisenachai N; Changrob S; Wangriatisak K; Muh F; Chootong P; Han ET
Malar J; 2019 May; 18(1):188. PubMed ID: 31151441
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
[TBL] [Abstract][Full Text] [Related]
3. The persistence of naturally acquired antibodies and memory B cells specific to rhoptry proteins of Plasmodium vivax in patients from areas of low malaria transmission.
Kochayoo P; Changrob S; Wangriatisak K; Lee SK; Chootong P; Han ET
Malar J; 2019 Nov; 18(1):382. PubMed ID: 31783870
[TBL] [Abstract][Full Text] [Related]
4. Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P. vivax infection.
Cheng Y; Wang B; Changrob S; Han JH; Sattabongkot J; Ha KS; Chootong P; Lu F; Cao J; Nyunt MH; Park WS; Hong SH; Lim CS; Tsuboi T; Han ET
Malar J; 2017 May; 16(1):211. PubMed ID: 28532483
[TBL] [Abstract][Full Text] [Related]
5. Main B-cell epitopes of PvAMA-1 and PvMSP-9 are targeted by naturally acquired antibodies and epitope-specific memory cells in acute and convalescent phases of vivax malaria.
Soares RR; Nakaie CR; Rodrigues-da-Silva RN; da Silva RL; Lima-Junior JDC; Scopel KKG
Parasite Immunol; 2020 May; 42(5):e12705. PubMed ID: 32096238
[TBL] [Abstract][Full Text] [Related]
6. Persistence of Long-lived Memory B Cells specific to Duffy Binding Protein in individuals exposed to Plasmodium vivax.
Changrob S; McHenry AM; Nyunt MH; Sattabongkot J; Han ET; Adams JH; Chootong P
Sci Rep; 2018 May; 8(1):8347. PubMed ID: 29844379
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
[TBL] [Abstract][Full Text] [Related]
8. Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax.
Lim KJ; Park JW; Yeom JS; Lee YH; Yoo SB; Oh JH; Sohn MJ; Bahk YY; Kim YS
Parasitol Res; 2004 Mar; 92(5):384-9. PubMed ID: 14745545
[TBL] [Abstract][Full Text] [Related]
9. Apical membrane protein 1-specific antibody profile and temporal changes in peripheral blood B-cell populations in Plasmodium vivax malaria.
Soares RR; Cunha CF; Ferraz-Nogueira R; Marins-Dos-Santos A; Rodrigues-da-Silva RN; da Silva Soares I; da Costa Lima-Junior J; Bertho AL; Ferreira MU; Scopel KKG
Parasite Immunol; 2019 Sep; 41(9):e12662. PubMed ID: 31271660
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women.
Requena P; Rui E; Padilla N; Martínez-Espinosa FE; Castellanos ME; Bôtto-Menezes C; Malheiro A; Arévalo-Herrera M; Kochar S; Kochar SK; Kochar DK; Umbers AJ; Ome-Kaius M; Wangnapi R; Hans D; Menegon M; Mateo F; Sanz S; Desai M; Mayor A; Chitnis CC; Bardají A; Mueller I; Rogerson S; Severini C; Fernández-Becerra C; Menéndez C; Del Portillo H; Dobaño C
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005009. PubMed ID: 27711158
[TBL] [Abstract][Full Text] [Related]
12. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin.
Ventocilla JA; Tapia LL; Ponce R; Franco A; Leelawong M; Aguiar JC; Baldeviano GC; Wilder BK
Malar J; 2024 May; 23(1):163. PubMed ID: 38783317
[TBL] [Abstract][Full Text] [Related]
14. Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax.
Wipasa J; Suphavilai C; Okell LC; Cook J; Corran PH; Thaikla K; Liewsaree W; Riley EM; Hafalla JC
PLoS Pathog; 2010 Feb; 6(2):e1000770. PubMed ID: 20174609
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of glycosylphosphatidylinositol-anchored micronemal antigen in natural Plasmodium vivax exposure.
Changrob S; Han JH; Ha KS; Park WS; Hong SH; Chootong P; Han ET
Malar J; 2017 Aug; 16(1):348. PubMed ID: 28830553
[TBL] [Abstract][Full Text] [Related]
16. Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).
Maestre A; Muskus C; Duque V; Agudelo O; Liu P; Takagi A; Ntumngia FB; Adams JH; Sim KL; Hoffman SL; Corradin G; Velez ID; Wang R
PLoS One; 2010 Jul; 5(7):e11437. PubMed ID: 20664684
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
Pandey JP; Morais CG; Fontes CJ; Braga EM
Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
[TBL] [Abstract][Full Text] [Related]
19. Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.
Oyong DA; Wilson DW; Barber BE; William T; Jiang J; Galinski MR; Fowkes FJI; Grigg MJ; Beeson JG; Anstey NM; Boyle MJ
J Infect Dis; 2019 Nov; 220(12):1950-1961. PubMed ID: 31419296
[TBL] [Abstract][Full Text] [Related]
20. Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7).
Cheng CW; Jongwutiwes S; Putaporntip C; Jackson AP
Malar J; 2019 Jun; 18(1):197. PubMed ID: 31196098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
